Researchers studying frontotemporal degeneration (FTD) disease, a leading cause of early onset dementia, will receive more than $30 million over the next five years in grants from the National Institutes of Health (NIH). The funding will be used to further scientific collaboration and investigate new treatments in the quest to find a cure for FTD.

Also, in Vancouver, Canada, on October 23rd, an FTD conference demonstrated the research progress made in this awakening field, with particular emphasis on the newly forged international collaborative relationships to comprehensively examine patients and their families in longitudinal cohort studies.


NIH Press Release
Vancouver FTD Conference detail on AlzForum

October 28, 2014